Regulation	0	10	O
of	11	13	O
tumor	14	19	B-Pathological_formation
angiogenesis	20	32	O
by	33	35	O
thrombospondin	36	50	B-Gene_or_gene_product
-	50	51	I-Gene_or_gene_product
1	51	52	I-Gene_or_gene_product
.	52	53	O

Angiogenesis	55	67	O
plays	68	73	O
a	74	75	O
critical	76	84	O
role	85	89	O
in	90	92	O
the	93	96	O
growth	97	103	O
and	104	107	O
metastasis	108	118	O
of	119	121	O
tumors	122	128	B-Pathological_formation
.	128	129	O

Thrombospondin	130	144	B-Gene_or_gene_product
-	144	145	I-Gene_or_gene_product
1	145	146	I-Gene_or_gene_product
(	147	148	O
TSP	148	151	B-Gene_or_gene_product
-	151	152	I-Gene_or_gene_product
1	152	153	I-Gene_or_gene_product
)	153	154	O
is	155	157	O
a	158	159	O
potent	160	166	O
angiogenesis	167	179	O
inhibitor	180	189	O
,	189	190	O
and	191	194	O
down	195	199	O
-	199	200	O
regulation	200	210	O
of	211	213	O
TSP	214	217	B-Gene_or_gene_product
-	217	218	I-Gene_or_gene_product
1	218	219	I-Gene_or_gene_product
has	220	223	O
been	224	228	O
suggested	229	238	O
to	239	241	O
alter	242	247	O
tumor	248	253	B-Pathological_formation
growth	254	260	O
by	261	263	O
modulating	264	274	O
angiogenesis	275	287	O
in	288	290	O
a	291	292	O
variety	293	300	O
of	301	303	O
tumor	304	309	B-Pathological_formation
types	310	315	O
.	315	316	O

Expression	317	327	O
of	328	330	O
TSP	331	334	B-Gene_or_gene_product
-	334	335	I-Gene_or_gene_product
1	335	336	I-Gene_or_gene_product
is	337	339	O
up	340	342	O
-	342	343	O
regulated	343	352	O
by	353	355	O
the	356	359	O
tumor	360	365	B-Pathological_formation
suppressor	366	376	O
gene	377	381	O
,	381	382	O
p53	383	386	B-Gene_or_gene_product
,	386	387	O
and	388	391	O
down	392	396	O
-	396	397	O
regulated	397	406	O
by	407	409	O
oncogenes	410	419	O
such	420	424	O
as	425	427	O
Myc	428	431	B-Gene_or_gene_product
and	432	435	O
Ras	436	439	B-Gene_or_gene_product
.	439	440	O

TSP	441	444	B-Gene_or_gene_product
-	444	445	I-Gene_or_gene_product
1	445	446	I-Gene_or_gene_product
inhibits	447	455	O
angiogenesis	456	468	O
by	469	471	O
inhibiting	472	482	O
endothelial	483	494	B-Cell
cell	495	499	I-Cell
migration	500	509	O
and	510	513	O
proliferation	514	527	O
and	528	531	O
by	532	534	O
inducing	535	543	O
apoptosis	544	553	O
.	553	554	O

In	555	557	O
addition	558	566	O
,	566	567	O
activation	568	578	O
of	579	581	O
transforming	582	594	B-Gene_or_gene_product
growth	595	601	I-Gene_or_gene_product
factor	602	608	I-Gene_or_gene_product
beta	609	613	I-Gene_or_gene_product
(	614	615	O
TGF	615	618	B-Gene_or_gene_product
-	618	619	I-Gene_or_gene_product
beta	619	623	I-Gene_or_gene_product
)	623	624	O
by	625	627	O
TSP	628	631	B-Gene_or_gene_product
-	631	632	I-Gene_or_gene_product
1	632	633	I-Gene_or_gene_product
plays	634	639	O
a	640	641	O
crucial	642	649	O
role	650	654	O
in	655	657	O
the	658	661	O
regulation	662	672	O
of	673	675	O
tumor	676	681	B-Pathological_formation
progression	682	693	O
.	693	694	O

An	695	697	O
understanding	698	711	O
of	712	714	O
the	715	718	O
molecular	719	728	O
basis	729	734	O
of	735	737	O
TSP	738	741	B-Gene_or_gene_product
-	741	742	I-Gene_or_gene_product
1	742	743	I-Gene_or_gene_product
-	743	744	O
mediated	744	752	O
inhibition	753	763	O
of	764	766	O
angiogenesis	767	779	O
and	780	783	O
tumor	784	789	B-Pathological_formation
progression	790	801	O
will	802	806	O
aid	807	810	O
in	811	813	O
the	814	817	O
development	818	829	O
of	830	832	O
novel	833	838	O
therapeutics	839	851	O
for	852	855	O
the	856	859	O
treatment	860	869	O
of	870	872	O
cancer	873	879	O
.	879	880	O

